The Effect of Exemestane on the Lipidemic Profile of Postmenopausal Early Breast Cancer Patients: Preliminary Results of the TEAM Greek Sub-study.

Autor: C. Markopoulos, A. Polychronis, V. Zobolas, G. Xepapadakis, J. Papadiamantis, D. Koukouras, H. Lappas, H. Gogas
Zdroj: Breast Cancer Research & Treatment; Aug2005, Vol. 93 Issue 1, p61-66, 6p
Abstrakt: Summary Introduction. Long-term endocrine therapy for breast cancer may have clinical implications as drugs that potentially alter the lipid profile may increase the risk of developing cardiovascular disease. In this study, a companion sub-protocol to the TEAM (Tamoxifen and Exemestane Adjuvant Multicenter) International trial, we compared the effect of the steroidal aromatase inactivator exemestane on the lipid profile of postmenopausal women with early breast cancer in the adjuvant setting to that of tamoxifen. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: